FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / pct-valuation-dcf-report.docx
pct-valuation-dcf-report.docx · 1018-00009

Parties

Contribution Transaction Valuation Analysis Inc
Flow Approach Penterra Pharmaceuticals Corp
Whitmore Valuation Group LLC
Harkness LLP
SUMMARY Whitmore Valuation Group LLC
Penterra Pharmaceuticals Corp
Associates LLP
Engagement Background Penterra Pharmaceuticals Corp

Dates

June 20, 2022
July 1, 2012
December 31, 2017
October 12, 2023
December 31, 2020
March 15, 2012
May 16, 2022
June 30, 2027

Amounts

$312,000,000
$540,000,000
$852,000,000
$380,400,000
$278,000,000
$361,000,000
$6.82
$1.47
$3.12
$1.87

Obligations

Under the best method rule, the arm's-length result of a controlled transaction must be determined under the method that, under the facts and circumstances, provides the most reliable measure of an arm's-length result
When a participant in a CSA makes available pre-existing resources, capabilities, or rights ("external contributions") to the CSA, the other participants must make platform contribution transaction payments to compensate the contributing participant for the value of those contributions
transferor is treated as having transferred the intangible property in exchange for payments contingent on the productivity, use, or disposition of such property, and must include in income for each taxable year amounts that would be commensurate with the income attributable to the transferred intangible
482-7(g)(4)(vi)(F) (the financial projections used in the income method "must be the most reliable projections
WVG notes that while the actual outcome is a useful reference point, it does not determine the appropriate as-of-date valuation; the valuation must be based on what was reasonably anticipated as of July 1, 2012